| Name | (3-aminooxalyl-1-benzyl-2-ethyl-1h-indol-4-yloxy)-acetic acid methyl ester |
|---|---|
| Synonyms | Varespladib methyl |
| Description | Varespladib methyl is a selective inhibitor of group II secretory phospholipase A2 (PLA2). |
|---|---|
| Related Catalog | |
| Target |
phospholipase A2 (PLA2)[1] |
| In Vitro | Varespladib methyl (LY333013) is an orally-administered methyl ester pro-drug that is metabolized to LY315920[1]. Varespladib and its orally bioavailable prodrug, Varespladib methyl (methyl-Varespladib) shows high-level secretory PLA2 (sPLA2) inhibition at nanomolar and picomolar concentrations against 28 medically important snake venoms from six continents[2]. |
| References |
| Molecular Formula | C22H22N2O5 |
|---|---|
| Molecular Weight | 394.42000 |
| Exact Mass | 394.15300 |
| PSA | 100.62000 |
| LogP | 3.17210 |
| Precursor 0 | |
|---|---|
| DownStream 1 | |